Market Price

55.99 

0.00 0.0%

as of Mar 04 '22

52 Week Range:

52.31 56.00


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Nuance Communications, Inc. provides conversational and cognitive artificial intelligence (AI) innovations that bring intelligence to everyday work and life. The company delivers solutions that understand, analyze, and respond to people - amplifying human intelligence to increase productivity and security. Its Healthcare segment provides clinical speech and clinical language understanding solutions that improve the clinical documentation process, from capturing the complete patient record to improving clinical documentation and quality measures for reimbursement. Its solutions include Dragon Medical One, cloud-based speech solution; computer-assisted physician documentation; diagnostic imaging solutions; Nuance Dragon Ambient eXperience, a voice-enabled solution; and clinical documentation improvement and coding. The company's Enterprise segment primarily engages in using speech, natural language understanding, and artificial intelligence to provide automated customer solutions and services for voice, mobile, web, and messaging channels. Its solutions include intelligent engagement solutions; Conversational AI; Engagement AI; and Security AI. Its Other segment provides voicemail transcription services. It serves organizations across healthcare, financial services, telecommunications, government, and retail. The company markets and sells its solutions and technologies directly through sales force, as well as through a network of resellers, including system integrators, independent software vendors, value-added resellers, distributors, hardware vendors, telecommunications carriers, and e-commerce Websites worldwide. The company was formerly known as ScanSoft, Inc. and changed its name to Nuance Communications, Inc. in October 2005. Nuance Communications, Inc. was incorporated in 1992 and is headquartered in Burlington, Massachusetts. As of March 4, 2022, Nuance Communications, Inc. operates as a subsidiary of Microsoft Corporation.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Sep '11 Sep '12 Sep '13 Sep '14 Sep '15 Sep '16 Sep '17 Sep '18 Sep '19 Sep '20 Sep '21
Equity (BVPS) 8.06
8.34
8.40
8.08
7.51
6.24
6.74
6.11
7.15
4.07
5.19
growth rate 3.5% 0.7% -3.8% -7.1% -16.9% 8.0% -9.4% 17.0% -43.1% 27.5%
Earnings BIT 30.02
65.30
-96.68
22.30
92.96
180.91
104.14
51.49
79.11
79.10
98.70
growth rate 117.5% -100.0% 100.0% 316.9% 94.6% -42.4% -50.6% 53.6% 0.0% 24.8%
Avg.PE 169.49
38.61
-22.60
-22.60
-22.60
-22.60
-62.25
-62.25
69.26
58.00
4,592.50
growth rate -77.2% -100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 100.0% -16.3% 7,818.1%
ROA 0.97
4.19
-1.96
-2.55
-2.02
-0.22
-2.60
-2.85
4.01
0.48
-0.77
growth rate 332.0% -100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 100.0% -88.0% -100.0%
ROE 1.60
7.95
-4.30
-5.76
-4.75
-0.59
-7.82
-8.77
11.04
1.30
-1.92
growth rate 396.9% -100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 100.0% -88.2% -100.0%
ROIC 1.85
6.38
-0.54
-0.49
-1.00
1.47
-1.31
-1.62
6.38
2.51
1.09
growth rate 244.9% -100.0% 0.0% 0.0% 100.0% -100.0% 0.0% 100.0% -60.7% -56.6%
Cur. Ratio 1.80
1.76
1.75
1.81
1.67
1.50
1.19
1.22
0.68
0.75
0.65
growth rate -2.2% -0.6% 3.4% -7.7% -10.2% -20.7% 2.5% -44.3% 10.3% -13.3%
Quick Ratio 1.60
1.57
1.52
1.58
1.45
1.39
1.12
1.09
0.57
0.58
0.40
growth rate -1.9% -3.2% 4.0% -8.2% -4.1% -19.4% -2.7% -47.7% 1.8% -31.0%
Leverage 1.65
2.13
2.26
2.25
2.47
2.93
3.07
3.09
2.49
3.14
2.07
growth rate 29.1% 6.1% -0.4% 9.8% 18.6% 4.8% 0.7% -19.4% 26.1% -34.1%
Balance Sheet Sep '11 Sep '12 Sep '13 Sep '14 Sep '15 Sep '16 Sep '17 Sep '18 Sep '19 Sep '20 Sep '21
Acct.Receivable 280.86
468.98
457.71
428.27
373.16
380.00
395.39
347.87
299.37
224.28
234.89
growth rate 67.0% -2.4% -6.4% -12.9% 1.8% 4.1% -12.0% -13.9% -25.1% 4.7%
Acct.Payable 258.78
328.37
305.24
61.76
56.58
94.60
94.60
80.91
90.83
71.83
90.12
growth rate 26.9% -7.0% -79.8% -8.4% 67.2% 0.0% -14.5% 12.3% -20.9% 25.5%
Cur.Assets 854.93
1,701.31
1,409.53
1,164.50
986.63
1,038.59
1,327.94
928.63
1,255.21
735.99
603.55
growth rate 99.0% -17.2% -17.4% -15.3% 5.3% 27.9% -30.1% 35.2% -41.4% -18.0%
Total Assets 4,095.29
5,799.04
5,958.60
5,820.28
5,511.91
5,661.47
5,931.92
5,302.38
5,365.79
3,593.33
3,386.65
growth rate 41.6% 2.8% -2.3% -5.3% 2.7% 4.8% -10.6% 1.2% -33.0% -5.8%
Cash 454.02
1,129.76
808.12
547.23
479.45
481.62
592.30
315.96
560.96
301.23
187.31
growth rate 148.8% -28.5% -32.3% -12.4% 0.5% 23.0% -46.7% 77.5% -46.3% -37.8%
Inventory 11.40
11.40
14.70
12.45
8.99
11.64
6.09
7.56
growth rate 0.0% 29.0% -15.3% -27.8% 29.4% -47.7% 24.2%
Cur.Liabilities 475.07
964.76
805.23
642.01
626.38
690.90
1,111.53
764.16
1,845.08
986.14
928.35
growth rate 103.1% -16.5% -20.3% -2.4% 10.3% 60.9% -31.3% 141.5% -46.6% -5.9%
Liabilities 1,601.92
3,052.33
3,320.59
3,238.29
3,246.66
3,730.14
4,000.54
3,584.88
3,192.64
2,449.40
1,751.72
growth rate 90.5% 8.8% -2.5% 0.3% 14.9% 7.3% -10.4% -10.9% -23.3% -28.5%
LT Debt 853.02
1,735.81
2,108.09
2,127.39
2,103.08
2,433.15
2,241.28
2,185.36
793.54
1,104.46
494.93
growth rate 103.5% 21.5% 0.9% -1.1% 15.7% -7.9% -2.5% -63.7% 39.2% -55.2%
Equity 2,493.37
2,728.28
2,638.01
2,581.99
2,265.25
1,931.33
1,931.38
1,717.50
2,155.01
1,143.93
1,634.93
growth rate 9.4% -3.3% -2.1% -12.3% -14.7% 0.0% -11.1% 25.5% -46.9% 42.9%
Common Shares 316.00
321.00
314.00
317.00
317.00
292.00
289.00
0.29
0.29
0.29
0.32
growth rate 1.6% -2.2% 1.0% 0.0% -7.9% -1.0% -99.9% -0.3% -1.0% 11.2%
Cash Flow Statement Sep '11 Sep '12 Sep '13 Sep '14 Sep '15 Sep '16 Sep '17 Sep '18 Sep '19 Sep '20 Sep '21
Capital Expenditures 34.91
62.91
55.59
60.29
58.04
54.88
61.84
48.85
44.19
61.30
56.51
growth rate 80.2% -11.6% 8.5% -3.7% -5.4% 12.7% -21.0% -9.5% 38.7% -7.8%
Cash Dividends 0.00 0.00
growth rate
Cash From OA 357.41
473.00
395.01
358.15
487.58
565.80
378.87
444.43
401.36
254.56
247.64
growth rate 32.3% -16.5% -9.3% 36.1% 16.0% -33.0% 17.3% -9.7% -36.6% -2.7%
FCF per Share 1.00
1.12
1.24
0.95
1.14
1.76
1.65
0.77
1.40
0.75
0.75
growth rate 12.0% 10.7% -23.4% 20.0% 54.4% -6.3% -53.3% 81.8% -46.4% 0.0%
Sale Purchase of Stock -0.24
-222.20
-214.69
22.65
25.78
16.85
17.38
growth rate 0.0% 0.0% 100.0% 13.8% -34.6% 3.2%
FCF 316.00
410.00
339.00
298.00
430.00
511.00
317.00
396.00
357.00
193.00
191.00
growth rate 29.8% -17.3% -12.1% 44.3% 18.8% -38.0% 24.9% -9.9% -45.9% -1.0%
Income Statement Sep '11 Sep '12 Sep '13 Sep '14 Sep '15 Sep '16 Sep '17 Sep '18 Sep '19 Sep '20 Sep '21
Sales 1,318.74
1,651.51
1,855.28
1,923.45
1,931.14
1,948.90
1,728.18
1,567.60
1,271.25
1,283.79
1,362.38
growth rate 25.2% 12.3% 3.7% 0.4% 0.9% -11.3% -9.3% -18.9% 1.0% 6.1%
Op.Income 38.24
207.14
-115.24
22.30
92.96
180.91
104.14
51.49
79.11
79.10
98.70
growth rate 441.7% -100.0% 100.0% 316.9% 94.6% -42.4% -50.6% 53.6% 0.0% 24.8%
IBT 30.02
65.30
-96.68
-155.02
-80.47
1.74
-154.67
-314.00
-64.80
-43.91
-11.96
growth rate 117.6% -100.0% 0.0% 0.0% 100.0% -100.0% 0.0% 0.0% 0.0% 0.0%
Net Income 38.24
207.14
-115.24
-150.34
-115.01
-12.46
-151.00
-159.93
213.81
21.40
-26.73
growth rate 441.7% -100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 100.0% -90.0% -100.0%
EPS 0.12
0.65
-0.37
-0.47
-0.36
-0.04
-0.52
-0.55
0.75
0.08
-0.09
growth rate 441.7% -100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 100.0% -89.3% -100.0%
Gross Profit 818.92
1,046.58
1,088.73
1,141.93
1,166.24
1,182.28
982.23
864.42
768.50
790.37
853.08
growth rate 27.8% 4.0% 4.9% 2.1% 1.4% -16.9% -12.0% -11.1% 2.9% 7.9%
R&D 179.38
225.44
289.21
333.78
306.87
271.13
239.93
207.19
181.78
219.92
249.20
growth rate 25.7% 28.3% 15.4% -8.1% -11.7% -11.5% -13.6% -12.3% 21.0% 13.3%

Quarterly Statements

Item Name Dec '20 Mar '21 Jun '21 Sep '21 Dec '21
Earnings BIT 40.44
44.00
22.78
-8.52
-12.88
growth rate 8.8% -48.2% -100.0% 0.0%
Balance Sheet Dec '20 Mar '21 Jun '21 Sep '21 Dec '21
Acct.Receivable 264.75
248.15
246.61
234.89
245.37
growth rate -6.3% -0.6% -4.8% 4.5%
Acct.Payable 81.46
77.16
85.77
90.12
75.33
growth rate -5.3% 11.2% 5.1% -16.4%
Cur.Assets 784.20
782.63
683.32
603.55
475.80
growth rate -0.2% -12.7% -11.7% -21.2%
Total Assets 3,647.69
3,594.08
3,467.53
3,386.65
3,236.56
growth rate -1.5% -3.5% -2.3% -4.4%
Cash 299.45
342.85
235.76
187.31
91.95
growth rate 14.5% -31.2% -20.6% -50.9%
Inventory
growth rate
Cur.Liabilities 1,596.08
1,586.39
993.65
928.35
841.16
growth rate -0.6% -37.4% -6.6% -9.4%
Liabilities 2,494.65
2,472.22
1,828.03
1,751.72
1,661.66
growth rate -0.9% -26.1% -4.2% -5.1%
LT Debt 495.98
494.30
494.67
494.93
495.19
growth rate -0.3% 0.1% 0.1% 0.1%
Equity 1,153.04
1,121.85
1,639.49
1,634.93
1,574.90
growth rate -2.7% 46.1% -0.3% -3.7%
Common Shares 0.29
0.29
0.32
0.32
0.32
growth rate 0.0% 9.0% 1.3% 1.3%
Cash Flow Statement Dec '20 Mar '21 Jun '21 Sep '21 Dec '21
Capital Expenditures 17.40
15.32
12.09
11.71
12.39
growth rate -12.0% -21.1% -3.1% 5.9%
Cash Dividends
growth rate
Cash From OA 61.19
88.43
47.84
50.18
13.85
growth rate 44.5% -45.9% 4.9% -72.4%
Sale Purchase of Stock
growth rate
FCF 43.79
73.11
35.75
38.47
1.46
growth rate 67.0% -51.1% 7.6% -96.2%
Income Statement Dec '20 Mar '21 Jun '21 Sep '21 Dec '21
Sales 345.75
346.98
336.58
333.07
321.44
growth rate 0.4% -3.0% -1.0% -3.5%
Op.Income 40.44
44.00
22.78
-8.52
-12.88
growth rate 8.8% -48.2% -100.0% 0.0%
IBT 9.26
17.56
-30.69
-8.09
-34.01
growth rate 89.7% -100.0% 0.0% 0.0%
Net Income 14.90
-3.63
-26.27
-11.72
-57.56
growth rate -100.0% 0.0% 0.0% 0.0%
EPS
growth rate
Gross Profit 218.24
225.27
211.91
197.67
186.77
growth rate 3.2% -5.9% -6.7% -5.5%
R&D 56.46
59.50
63.70
69.55
68.17
growth rate 5.4% 7.1% 9.2% -2.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

F (0.00)

YOY Growth Grade:

F (0.00)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

Current EPS is negative, therefore value price cannot be calculated.

PE and EPS

Historical Current Forward
PE 4,592.50 -608.59 69.12
EPS / Growth -1.8% -0.09 5.2%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 1.0%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 1.0% 1.0% 1.0%
Future PE 2.00 35.56 35.56
Future EPS 0.00 0.00 0.00
Value Price
MOS %
0.00
-100.0%
0.00
-100.0%
0.00
-100.0%
MOS Price 0.00 0.00 0.00
IRT 99.00 99.00 99.00

Graham Number:

Current EPS is negative, therefore Graham Number cannot be calculated.
NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.